← Leaderboards
Richard A Flavell
Yale University
$31,785,615
Attributed
$41,707,577
Total exposure
38
Grants
23
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$51,102,254 · 39
By mechanism
R01$26,010,355 · 12
P01$12,350,089 · 7
P30$3,883,877 · 5
R21$2,059,370 · 5
UG3$1,635,697 · 1
P50$1,518,872 · 2
Top collaborators
- Ryan C Fields8 shared
- Madhav V Dhodapkar7 shared
- Erol Fikrig5 shared
- Markus Gabriel Manz5 shared
- Joseph E Craft3 shared
- Anna Karolina Palucka3 shared
- Wajahat Zafar Mehal2 shared
- Noah Wolcott Palm2 shared
Most similar at Yale University
Same institution · by research overlap
- Mary E. Choi$7,200,453
- Rafael Klorman Klorman$2,633,664
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMouse ModelImmuneResponseIn VivoGenetically Modified AnimalsImmune SystemGenesGeneticImmune ResponseMediatingSignal TransductionHumanized MouseAnimal ModelMolecularTumorResearch PersonnelTechnologyT-LymphocyteCd34 GeneCytokineLaboratory MouseCommunitiesDiabetes Mellitus
Grant awards (131)
Targeting microbial triggers of gammopathy for immunoprevention$846,118
UG3 · FY2025 · CA
Non-parenchymalcells drive the key features of alcohol associated hepatitis (AAH) in a fully humanized mouse liver$688,199
R01 · FY2025 · AA · contact PI
Explore the role of hepatocyte inflammasome in alcoholic liver disease$253,383
R21 · FY2025 · AA · contact PI
Regulation of hematopoiesis and trained immunity by innate lymphocytes$203,094
R21 · FY2025 · AI · contact PI
Molecular Genetics Core$96,944
P30 · FY2025 · DK · contact PI
Targeting microbial triggers of gammopathy for immunoprevention$789,579
UG3 · FY2024 · CA
Advancing Precision Oncology in a Humanized, Fully Autologous Mouse Model$569,047
R01 · FY2024 · CA
Regulation of hematopoiesis and trained immunity by innate lymphocytes$251,250
R21 · FY2024 · AI · contact PI
Animal Modeling Core$220,277
U54 · FY2024 · DK · contact PI
Investigation of Dpp9 in COVID19$209,162
R21 · FY2024 · AI · contact PI
Molecular Genetics Core$96,944
P30 · FY2024 · DK · contact PI
Advancing Precision Oncology in a Humanized, Fully Autologous Mouse Model$587,012
R01 · FY2023 · CA
Investigation of Dpp9 in COVID19$244,919
R21 · FY2023 · AI · contact PI
Animal Modeling Core$220,014
U54 · FY2023 · DK · contact PI
Molecular Genetics Core$96,944
P30 · FY2023 · DK · contact PI
Advancing Precision Oncology in a Humanized, Fully Autologous Mouse Model$587,011
R01 · FY2022 · CA
The role of NLRP6 and DHX15 in control of infection by RNA viruses$418,750
R01 · FY2022 · AI
The Inflammasome as a novel mediator and therapeutic target of GI syndrome$375,493
R01 · FY2022 · CA · contact PI
Molecular Genetics Mouse Core$317,043
P30 · FY2022 · DK · contact PI
Animal Modeling Core$220,805
U54 · FY2022 · DK · contact PI
Generation and characterization of a humanized mouse model of alcoholic liver disease$198,906
R21 · FY2022 · AA · contact PI
Generation and characterization of a humanized mouse model of Crohn's disease$83,750
R03 · FY2022 · AI
Advancing Precision Oncology in a Humanized, Fully Autologous Mouse Model$598,999
R01 · FY2021 · CA
The role of NLRP6 and DHX15 in control of infection by RNA viruses$418,750
R01 · FY2021 · AI
The Inflammasome as a novel mediator and therapeutic target of GI syndrome$383,156
R01 · FY2021 · CA · contact PI
Molecular Genetics Mouse Core$317,041
P30 · FY2021 · DK · contact PI
Animal Modeling Core$273,764
U54 · FY2021 · DK · contact PI
Generation and characterization of a humanized mouse model of alcoholic liver disease$240,781
R21 · FY2021 · AA · contact PI
Generation and characterization of a humanized mouse model of Crohn's disease$83,750
R03 · FY2021 · AI
Advancing Precision Oncology in a Humanized, Fully Autologous Mouse Model$612,841
R01 · FY2020 · CA
The role of NLRP6 and DHX15 in control of infection by RNA viruses$418,750
R01 · FY2020 · AI
The Inflammasome as a novel mediator and therapeutic target of GI syndrome$383,156
R01 · FY2020 · CA · contact PI
Molecular Genetics Mouse Core$317,043
P30 · FY2020 · DK · contact PI
Animal Modeling Core$273,764
U54 · FY2020 · DK · contact PI
Towards True Precision Oncology: Validation of a Comprehensively Humanized, Autologous Mouse Model$584,722
R01 · FY2019 · CA
The role of NLRP6 and DHX15 in control of infection by RNA viruses$418,750
R01 · FY2019 · AI
An in vivo CRISPR-Cas9 genetic screen in murine primary T cells to discover metabolic regulators of follicular B helper T (Tfh) cell differentiation$417,953
R33 · FY2019 · AR
The Inflammasome as a novel mediator and therapeutic target of GI syndrome$371,660
R01 · FY2019 · CA · contact PI
Molecular Genetics Mouse Core$317,041
P30 · FY2019 · DK · contact PI
Towards True Precision Oncology: Validation of a Comprehensively Humanized, Autologous Mouse Model$588,621
R01 · FY2018 · CA
The role of NLRP6 and DHX15 in control of infection by RNA viruses$418,750
R01 · FY2018 · AI
An in vivo CRISPR-Cas9 genetic screen in murine primary T cells to discover metabolic regulators of follicular B helper T (Tfh) cell differentiation$414,083
R61 · FY2018 · AR
The Inflammasome as a novel mediator and therapeutic target of GI syndrome$383,156
R01 · FY2018 · CA · contact PI
Molecular Genetics Mouse Core$317,041
P30 · FY2018 · DK · contact PI
Towards True Precision Oncology: Validation of a Comprehensively Humanized, Autologous Mouse Model$642,825
R01 · FY2017 · CA
Humanized mouse models to dissect in vivo the interplay between melanoma and the immune system$439,280
R01 · FY2017 · CA
An in vivo CRISPR-Cas9 genetic screen in murine primary T cells to discover metabolic regulators of follicular B helper T (Tfh) cell differentiation$395,514
R61 · FY2017 · AR
MOLECULAR Genetic Mouse CORE$296,593
P30 · FY2017 · DK · contact PI
Humanized mouse models to dissect in vivo the interplay between melanoma and the immune system$442,010
R01 · FY2016 · CA
MOLECULAR Genetic Mouse CORE$296,594
P30 · FY2016 · DK · contact PI
Humanized mouse models to dissect in vivo the interplay between melanoma and the immune system$467,188
R01 · FY2015 · CA
MOLECULAR Genetic Mouse CORE$296,594
P30 · FY2015 · DK · contact PI
Identifying lincRNAs critical in asthma pathogenesis$208,125
R21 · FY2015 · AI · contact PI
Understanding Hemotopoietic Neoplasias using Humanized Mice$966,410
R01 · FY2014 · CA · contact PI
MOLECULAR Genetic Mouse CORE$296,594
P30 · FY2014 · DK · contact PI
Identifying lincRNAs critical in asthma pathogenesis$249,750
R21 · FY2014 · AI · contact PI
Understanding Hemotopoietic Neoplasias using Humanized Mice$946,541
R01 · FY2013 · CA · contact PI
The role of Bcl-Rambo in thymic involution$405,516
R01 · FY2013 · AI · contact PI
MOLECULAR Genetic Mouse CORE$352,070
P30 · FY2013 · DK · contact PI
Understanding Hemotopoietic Neoplasias using Humanized Mice$990,065
R01 · FY2012 · CA · contact PI
The role of Bcl-Rambo in thymic involution$405,516
R01 · FY2012 · AI · contact PI
Understanding Hemotopoietic Neoplasias using Humanized Mice$1,025,153
R01 · FY2011 · CA · contact PI
The role of Bcl-Rambo in thymic involution$405,516
R01 · FY2011 · AI · contact PI
Pathogenesis and prevention of autoimmune diabetes$299,361
R01 · FY2011 · DK · contact PI
Understanding Hemotopoietic Neoplasias using Humanized Mice$1,063,218
R01 · FY2010 · CA · contact PI
Understanding the role of AMCase in asthma$500,000
RC1 · FY2010 · HL · contact PI
The role of Bcl-Rambo in thymic involution$409,613
R01 · FY2010 · AI · contact PI
Pathogenesis and prevention of autoimmune diabetes$302,385
R01 · FY2010 · DK · contact PI
ENHANCEMENT OF ANTI-TUMOR IMMUNITY BY INHIBITION OF TGF-B SIGNALING IN PATIENS WI$256,461
P50 · FY2010 · CA · contact PI
Understanding the role of AMCase in asthma$500,000
RC1 · FY2009 · HL · contact PI
The role of Bcl-Rambo in thymic involution$413,750
R01 · FY2009 · AI · contact PI
Pathogenesis and prevention of autoimmune diabetes$305,440
R01 · FY2009 · DK · contact PI
ENHANCEMENT OF ANTI-TUMOR IMMUNITY BY INHIBITION OF TGF-B SIGNALING IN PATIENS WI$256,461
P50 · FY2009 · CA · contact PI
Pathogenesis and prevention of autoimmune diabetes$305,440
R01 · FY2008 · DK · contact PI
Roles of Nod2 in the Pathogenesis of Crohn's Disease$285,623
R01 · FY2008 · DK · contact PI
ENHANCEMENT OF ANTI-TUMOR IMMUNITY BY INHIBITION OF TGF-B SIGNALING IN PATIENS WI$256,461
P50 · FY2008 · CA · contact PI
Vaccine responsiveness to Borrelia burgdorferi OspA$387,569
R01 · FY2007 · AI · contact PI
Pathogenesis and prevention of autoimmune diabetes$310,811
R01 · FY2007 · DK · contact PI
The Role of IL-2 in Autoimmune Diabetes$310,055
R01 · FY2007 · DK · contact PI
Roles of Nod2 in the Pathogenesis of Crohn's Disease$291,452
R01 · FY2007 · DK · contact PI
ENHANCEMENT OF ANTI-TUMOR IMMUNITY BY INHIBITION OF TGF-B SIGNALING IN PATIENS WI$256,461
P50 · FY2007 · CA · contact PI
Dys/Regulation of the Immune System in Autoimmunity$1,787,416
P01 · FY2006 · AI · contact PI
Vaccine responsiveness to Borrelia burgdorferi OspA$399,144
R01 · FY2006 · AI · contact PI
The Role of IL-2 in Autoimmune Diabetes$319,316
R01 · FY2006 · DK · contact PI
ICOS in allergic airway responses$307,227
P01 · FY2006 · HL · contact PI
CORE--TRANSGENIC AND GENE TARGETING$307,227
P01 · FY2006 · HL · contact PI
Roles of Nod2 in the Pathogenesis of Crohn's Disease$300,157
R01 · FY2006 · DK · contact PI
ENHANCEMENT OF ANTI-TUMOR IMMUNITY BY INHIBITION OF TGF-B SIGNALING IN PATIENS WI$140,694
P50 · FY2006 · CA · contact PI
Dys/Regulation of the Immune System in Autoimmunity$1,735,126
P01 · FY2005 · AI
Vaccine responsiveness to Borrelia burgdorferi OspA$408,750
R01 · FY2005 · AI
The Role of IL-2 in Autoimmune Diabetes$327,000
R01 · FY2005 · DK
Immunoregulatory Mechanisms in Autoimmune Diabetes$307,906
R01 · FY2005 · DK
Roles of Nod2 in the Pathogenesis of Crohn's Disease$307,380
R01 · FY2005 · DK
CORE--TRANSGENIC AND GENE TARGETING$298,777
P01 · FY2005 · HL
ICOS in allergic airway responses$298,777
P01 · FY2005 · HL
Dys/Regulation of the Immune System in Autoimmunity$1,684,589
P01 · FY2004 · AI
Vaccine responsiveness to Borrelia burgdorferi OspA$408,750
R01 · FY2004 · AI
The Role of IL-2 in Autoimmune Diabetes$327,000
R01 · FY2004 · DK
Roles of Nod2 in the Pathogenesis of Crohn's Disease$307,380
R01 · FY2004 · DK
Immunoregulatory Mechanisms in Autoimmune Diabetes$298,938
R01 · FY2004 · DK
Roles of bacterial flora in endotoxin shock mediated vi*$40,320
R03 · FY2004 · TW
Dys/Regulation of the Immune System in Autoimmunity$1,664,523
P01 · FY2003 · AI
IL-2 in Autoimmune Diabetes$327,000
R01 · FY2003 · DK
Immunoregulatory Mechanisms in Autoimmune Diabetes$290,230
R01 · FY2003 · DK
Vaccine responsiveness to Borrelia burgdorferi OspA$286,125
R01 · FY2003 · AI
Dys/Regulation of the Immune System in Autoimmunity$803,353
P01 · FY2002 · AI
Immunoregulatory Mechanisms in Autoimmune Diabetes$281,778
R01 · FY2002 · DK
ICOS in allergic airway responses$280,238
P01 · FY2002 · HL
ROLE OF MHC CLASS 2 MOLECULES ON THE DEVELOPMENT OF T CELL TOLERANCE$180,000
P01 · FY2002 · DK
CORE--TRANSGENIC AND GENE TARGETING$165,355
P01 · FY2002 · HL
CORE--TRANSGENIC$0
P30 · FY2002 · DK
CORE--TRANSGENIC$0
P30 · FY2002 · DK
CORE--TRANSGENIC$0
P30 · FY2002 · DK
Role of IL-10 in the Regulation of Autoimmune Disease$0
P01 · FY2002 · AI
DYSREGULATION OF THE IMMUNE SYSTEM IN AUTOIMMUNITY$872,544
P01 · FY2001 · AI
Immunoregulatory Mechanisms in Autoimmune Diabetes$273,571
R01 · FY2001 · DK
CORE--TRANSGENIC$254,111
P30 · FY2001 · DK
SELECTIN IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS$247,465
P01 · FY2001 · AI
CORE--TRANSGENIC ANIMAL RESOURCE$247,465
P01 · FY2001 · AI
ROLE OF MHC CLASS 2 MOLECULES ON THE DEVELOPMENT OF T CELL TOLERANCE$180,000
P01 · FY2001 · DK
CORE--TRANSGENIC$165,355
P50 · FY2001 · HL
CORE--TRANSGENIC$0
P30 · FY2001 · DK
CORE--TRANSGENIC$0
P30 · FY2001 · DK
CORE--TRANSGENIC$0
P30 · FY2001 · DK
DYSREGULATION OF THE IMMUNE SYSTEM IN AUTOIMMUNITY$847,126
P01 · FY2000 · AI
CORE--TRANSGENIC$215,280
P30 · FY2000 · DK
PATHOGENESIS AND PREVENTION OF AUTOIMMUNE DIABETES$212,370
R01 · FY2000 · DK
CORE--TRANSGENIC$186,979
P50 · FY2000 · HL
ROLE OF MHC CLASS 2 MOLECULES ON THE DEVELOPMENT OF T CELL TOLERANCE$176,207
P01 · FY2000 · DK
CORE--TRANSGENIC ANIMAL RESOURCE$133,337
P01 · FY2000 · AI
SELECTIN IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS$133,337
P01 · FY2000 · AI